LGVAX | VIVIX | LGVAX / VIVIX | |
Total Expense Ratio | 1.01 | 0.04 | 2,525% |
Annual Report Gross Expense Ratio | 1.04 | 0.04 | 2,600% |
Fund Existence | 17 years | 27 years | - |
Gain YTD | 6.123 | 7.866 | 78% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.9B | 203B | 2% |
Annual Yield % from dividends | 0.75 | 2.11 | 35% |
Returns for 1 year | 1.79 | 7.74 | 23% |
Returns for 3 years | 16.10 | 36.61 | 44% |
Returns for 5 years | 29.66 | 70.16 | 42% |
Returns for 10 years | 70.63 | 131.61 | 54% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HLMIX | 29.16 | 0.28 | +0.97% |
Harding Loevner International Eq Instl | |||
PEGCX | 20.32 | 0.05 | +0.25% |
PGIM Jennison Mid-Cap Growth C | |||
TRGPX | 23.33 | 0.02 | +0.09% |
Nuveen Quant Mid Cap Growth Premier | |||
QMGAX | 12.86 | N/A | N/A |
Invesco Advantage International A | |||
MUXRX | 27.97 | -0.09 | -0.32% |
Victory S&P 500 Index R |